We are live on !
Find out more
Paulson & Co Portfolio holdings
AUM
$2.58B
Turnover
30%
1-Year Est. Return
68.51%
Paulson & Co. is the investment firm John Paulson, its founder and president, started in 1994 and ran as a hedge fund, which made its name with a 2007 bet against the subprime mortgage market. For that bet, it bought credit default swaps, a form of insurance on debt that it did not own. It focused on mergers, event-driven trades and credit, buying undervalued takeover targets and pushing as a large shareholder for higher bids. Since 2020 it has been a family office that invests Paulson's own money.
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$7.4B
AUM Growth
-$138M
(-1.8%)
Cap. Flow
-$418M
Cap. Flow % of AUM
Cap. Flow %
-5.65%
Top 10 Holdings %
Top 10 Hldgs %
57.17%
Holding
127
New
29
Increased
18
Reduced
38
Closed
18
Avg Time Held
Equity + Options
1.3
years
Top 10 Avg Time Held
Equity + Options
1.3
years
Top 20 Avg Time Held
Equity + Options
1.5
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$182M |
| 2 |
AABA
Altaba Inc
AABA
|
+$146M |
| 3 |
T-Mobile US
TMUS
|
+$124M |
| 4 |
VWR
VWR Corporation
VWR
|
+$83.7M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$61.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
|
+$328M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$202M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$132M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$105M |
| 5 |
SHPG
Shire pic
SHPG
|
+$90.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.28% |
| 2 | Communication Services | 14.29% |
| 3 | Miscellaneous | 9.96% |
| 4 | Consumer Discretionary | 8.53% |
| 5 | Materials | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $657M | 8.89% |
2,703,570
-238,264
| -8% | -$56M |
2014 Q1
13 quarters
|
|
2
Viatris
VTRS
$23.9B
| $619M | 8.36% |
15,933,600
-1,340,787
| -8% | -$51.5M |
2013 Q2
16 quarters
|
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $575M | 7.78% |
3,481,600
-516,500
| -13% | -$90.3M |
2013 Q2
16 quarters
|
|
4
SPDR Gold Trust
GLD
$130B
| $515M | 6.96% |
4,359,722
| – | – |
2013 Q2
16 quarters
|
|
5
Bausch Health
BHC
$3.13B
| $377M | 5.1% |
21,813,400
+2,428,900
| +13% | +$29.1M |
2014 Q1
13 quarters
|
|
|
6
T-Mobile US
TMUS
$180B
| $367M | 4.96% |
6,050,700
+1,910,600
| +46% | +$124M |
2017 Q1
1 quarter
|
|
|
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $309M | 4.18% |
6,891,372
-609,600
| -8% | -$26.7M |
2013 Q3
15 quarters
|
|
|
TWX
8
DELISTED
Time Warner Inc
TWX
| $300M | 4.05% |
2,986,455
-37,545
| -1% | -$3.72M |
2016 Q4
2 quarters
|
|
9
American International
AIG
$43B
| $259M | 3.5% |
4,140,763
-407,830
| -9% | -$25.3M |
2015 Q1
9 quarters
|
|
|
DISH
10
DELISTED
DISH Network Corp.
DISH
| $251M | 3.39% |
3,998,800
+548,700
| +16% | +$34.6M |
2017 Q1
1 quarter
|
|
|
CACQ
11
DELISTED
Caesars Acquisition Company
CACQ
| $250M | 3.38% |
13,117,998
| – | – |
2013 Q4
14 quarters
|
|
|
12
Teva Pharmaceutical Industries Limited
TEVA
$51.9B
| $224M | 3.03% |
6,744,000
-4,253,300
| -39% | -$132M |
2015 Q2
8 quarters
|
|
|
13
Vistra
VST
$45.1B
| $194M | 2.62% |
+11,530,556
| New | +$182M |
2017 Q2
0 quarters
|
|
14
DELISTED
Caesars Entertainment Corporation
CZR
| $173M | 2.34% |
14,417,900
| – | – |
2013 Q2
16 quarters
|
|
|
AABA
15
DELISTED
Altaba Inc
AABA
| $146M | 1.97% |
+2,675,000
| New | +$146M |
2017 Q2
0 quarters
|
|
16
NXP Semiconductors
NXPI
$66.8B
| $131M | 1.78% |
1,200,664
+68,364
| +6% | +$7.32M |
2016 Q4
2 quarters
|
|
17
DELISTED
Anywhere Real Estate
HOUS
| $130M | 1.75% |
4,000,000
-785,000
| -16% | -$23.8M |
2013 Q2
16 quarters
|
|
18
AngloGold Ashanti
AU
$43.7B
| $124M | 1.68% |
12,782,400
| – | – |
2013 Q2
16 quarters
|
|
|
SGYP
19
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $107M | 1.45% |
24,088,655
| – | – |
2015 Q1
9 quarters
|
|
20
NovaGold Resources
NG
$2.47B
| $100M | 1.36% |
21,992,896
-137,800
| -0.6% | -$593K |
2013 Q2
16 quarters
|
|
|
VWR
21
DELISTED
VWR Corporation
VWR
| $88.3M | 1.19% |
+2,675,200
| New | +$83.7M |
2017 Q2
0 quarters
|
|
22
TIM SA
TIMB
$9.07B
| $82.1M | 1.11% |
5,550,600
-61,300
| -1% | -$946K |
2014 Q2
12 quarters
|
|
|
WLH
23
DELISTED
WILLIAM LYON HOMES
WLH
| $80.2M | 1.08% |
3,322,666
| – | – |
2013 Q2
16 quarters
|
|
|
ENDP
24
DELISTED
Endo International plc
ENDP
| $80.1M | 1.08% |
7,174,490
-664,410
| -8% | -$7.8M |
2015 Q3
7 quarters
|
|
25
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $75.4M | 1.02% |
6,263,526
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
CL
FFH
Paulson & Co's Q2 2017 Portfolio in Review
As of Q2 2017, Paulson & Co held 127 positions worth $7.4B, down 1.8% from $7.53B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Paulson & Co withdrew a net $418M in Q2 2017, closing 18 positions and reducing 38 holdings. Its most notable exit was Akorn Inc, an estimated $202M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 49% a quarter earlier, followed by Communication Services and Miscellaneous.
Against the trend, Paulson & Co opened a new position in Vistra worth $194M.
- Paulson & Co's largest Q2 2017 buy was Vistra: 11,530,556 shares worth $194M.
- Paulson & Co added most to T-Mobile US in Q2 2017, an estimated $124M increase.
- Paulson & Co's biggest Q2 2017 reduction was Extended Stay America, Inc. Paired Share Unit, cutting an estimated $328M.
- Paulson & Co fully exited Akorn Inc in Q2 2017, selling an estimated $202M.
- Paulson & Co's ten largest holdings make up 57% of its $7.4B portfolio in Q2 2017.
- Paulson & Co opened 29 new positions and closed 18 in Q2 2017.
- Paulson & Co's portfolio value fell 1.8% quarter-over-quarter to $7.4B.
Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.